Accueil   Diary - News   All news Sanofi Pasteur’s dengue vaccine approved in the Philippines

Sanofi Pasteur’s dengue vaccine approved in the Philippines

SANOFI Pasteur - RVB - Colors

Dengvaxia ®’s first a pproval in Asia reaffirms company’s vision for priority introduction of the dengue vaccine in endemic countries globally.



Sanofi Pasteur, the vaccines division of Sanofi, announced today that the Philippines have granted marketing approval to Dengvaxia®, making it the first vaccine to be licensed for the prevention of dengue in Asia.


 Read the press release


By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to More details are available by clicking here I agree